Ceribell EEG

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care.

Ceribell’s mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro™ AI algorithm is the first and only FDA-indicated software for the diagnosis of Electrographic Status Epilepticus with U.S. Centers for Medicare and Medicaid Services approved New Technology Add-on Payment (NTAP).

03/02/2026

Thank you to the organizers and to all the and nurses who stopped by our booth!
All of us at Ceribell look forward to partnering with you to reimagine neonatal brain care with 24/7 continuous —without the wait.
Missed us at the conference? You can still see what all the excitement is about—Learn more and sign up to get in touch: https://ceribell.com/neonate/

02/27/2026

It’s the final day of !
We’ve been thrilled by the great feedback from and nurses. If you haven’t stopped by yet, come visit us at booth 312 for a live demo of our , designed specifically for neonatal patients.

02/25/2026

Ceribell debuts at the NEO Pediatrix Conference 2026!
We’re introducing our new Point-of-Care EEG designed for . Stop by our booth for a hands-on experience with 24/7 continuous , empowered by AI to detect electrographic seizures in newborns — preterm and up.

02/22/2026

Thank you to everyone who visited us at ! We loved connecting with so many passionate and sharing our vision for accessible, rapid monitoring. Your insights inspire us to keep innovating for better patient care. Missed us? Connect with our team: https://ceribell.com/demo/

02/21/2026

Final day at ! Want to learn about the latest scientific evidence on AI-powered detection? Talk directly with our researchers at the poster presentation from 1:00 to 2:00 PM. Then visit the Ceribell booth #401 to see our innovations in action. Don't miss out! https://ceribell.com

CAUTION: Device does not substitute for EEG review by a qualified clinician. Before use, review the manual for indications, contraindications, warnings, precautions, potential adverse events and Instructions for Use. Sale requires the order of a physician.

02/20/2026

Don't miss the Innovation Technology Lab at ! Hear Dr. Josef Parvizi, Ceribell’s co-founder, share what sets our point-of-care EEG technology apart. Discover how we're transforming detection in critically ill patients from neonates to adults. Stop by our booth #401 to learn more! https://ceribell.com

02/19/2026

Today! Visit booth at to experience our four game-changing innovations shaped by . Test drive Custom Notifications, Smart EEG Reports, Clarity® with Insights Bar, and EMR Integration and see how they improve care and boost workflow. https://ceribell.com/neuro-bundle-launch/

,

02/16/2026

Attention !

Struggling to meet ACNS guidelines for neonatal seizure monitoring? This educational symposium is for you. Join us to learn from a pediatric and neonatal neurology expert sharing the first-hand experience using Ceribell point-of-care EEG to support neonatal brain care.

Reserve your seat today: https://ceribell.com/neo-symposium/

02/13/2026

We’re excited to showcase at our 24/7 continuous solution for critically ill . Discover how we're advancing rapid EEG access for the most vulnerable patients. https://ceribell.com/neonate/

02/11/2026

New! 2026 AHA/ASA Guideline for Acute Ischemic Stroke

The 2026 American Heart Association/American Stroke Association ( ) guideline recognizes that acute ischemic increases risk—and that poststroke seizures are associated with higher mortality and disability.

Ceribell Point-of-Care EEG supports innovation in early seizure detection and provides continuous brain monitoring, helping clinicians make timely, informed decisions that may improve neurological outcomes during acute stroke evaluation.

Learn more about the new guideline: https://doi.org/10.1161/STR.0000000000000513

02/09/2026

Heading to the NEO Pediatrix Conference in Las Vegas this February?
Join our educational breakfast symposium to learn about the new point-of-care EEG designed for neonatal patients at risk of non-convulsive .
Reserve your spot today: https://ceribell.com/neo-symposium/

02/07/2026

In case you missed us at , watch this case study where a stroke code patient was found to have suspected non-convulsive status epilepticus ( ) after imaging ruled out .

See how enables rapid seizure detection and informs timely treatment decisions.
https://ceribell.com/evidence/clinical-studies/ -stroke-study

Address

360 N Pastoria Avenue
Sunnyvale, CA
94085

Telephone

+18004360826

Website

http://Ceribell.com/

Alerts

Be the first to know and let us send you an email when Ceribell EEG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ceribell EEG:

Shortcuts

Want your practice to be the top-listed Clinic in Sunnyvale?